Table 2.
Baseline participant characteristics
| | | N = 55 |
|---|---|---|
| Age, years | 71 | (66–78) |
| Male, N | 38 | (69.0) |
| BMI, kg/m2 | 26.6 | (23.5–28.8) |
| Systolic blood pressure, mm Hg | 132.0 | (122.0–141.5) |
| Diastolic blood pressure, mm Hg | 70.0 | (63.0–79.5) |
| UACR, mg/gCre | 155.0 | (73.4–348.2) |
| Serum creatinine, mg/dL | 0.85 | (0.70–0.95) |
| eGFR, mL/min/1.73 m2 | 66.7 | (57.5–73.5) |
| Cystatin C, mg/L | 0.99 | (0.86–1.11) |
| Serum potassium, mmol/L | 4.20 | (4.0–4.4) |
| UA, μmol/L | 339.0 | (285.5–377.7) |
| HbA1c, % | 7.2 | (6.8–7.7) |
| Triglyceride, mmol/L | 1.65 | (1.10–2.26) |
| HDL cholesterol, mmol/L | 1.27 | (1.07–1.49) |
| LDL cholesterol, mmol/L | 2.55 | (2.13–2.85) |
| Aldosterone, pg/mL | 104.0 | (73.3–127.1) |
| Duration of diabetes, N | ||
| ≥10 years | 18 | (32.7) |
| <10 years | 37 | (67.3) |
| eGFR, N | ||
| ≥60 mL/min/1.73 m2 | 40 | (72.7) |
| <60 mL/min/1.73 m2 | 15 | (27.3) |
| UACR, N | ||
| 30 to <300 mg/gCre | 38 | (69.1) |
| ≥300 mg/gCre | 17 | (30.9) |
BMI, body mass index; UACR, urine albumin-to-creatinine ratio; eGFR, estimated glomerular filtration rate; UA, uric acid; HDL, high-density lipoprotein; LDL, low-density lipoprotein; HbA1c, glycated hemoglobin.